Castlight Health, inc. (NYSE:CSLT) has been assigned a consensus rating of “Hold” from the ten research firms that are currently covering the stock, Marketbeat Ratings reports. Two analysts have rated the stock with a sell recommendation, six have given a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $4.46.

A number of equities research analysts recently weighed in on CSLT shares. Chardan Capital started coverage on shares of Castlight Health, inc. in a report on Tuesday, June 6th. They set a “buy” rating and a $4.50 price objective for the company. Dougherty & Co started coverage on shares of Castlight Health, inc. in a report on Wednesday, May 10th. They set a “buy” rating and a $5.50 price objective for the company. Zacks Investment Research upgraded shares of Castlight Health, inc. from a “sell” rating to a “hold” rating in a report on Tuesday, June 27th. ValuEngine lowered shares of Castlight Health, inc. from a “hold” rating to a “sell” rating in a report on Friday, May 19th. Finally, Morgan Stanley downgraded shares of Castlight Health, inc. from an “equal weight” rating to an “underweight” rating and cut their target price for the company from $4.00 to $3.75 in a research report on Friday, May 12th.

ILLEGAL ACTIVITY NOTICE: “Castlight Health, inc. (CSLT) Given Consensus Rating of “Hold” by Analysts” was published by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another publication, it was illegally copied and reposted in violation of US and international trademark and copyright law. The legal version of this article can be viewed at https://www.americanbankingnews.com/2017/07/10/castlight-health-inc-cslt-given-consensus-rating-of-hold-by-analysts.html.

Castlight Health, inc. (CSLT) opened at 4.25 on Monday. The company’s 50 day moving average is $3.88 and its 200 day moving average is $3.83. Castlight Health, inc. has a 12 month low of $3.05 and a 12 month high of $5.50. The stock’s market cap is $554.68 million.

Castlight Health, inc. (NYSE:CSLT) last announced its quarterly earnings data on Wednesday, April 26th. The software maker reported ($0.05) earnings per share for the quarter, meeting analysts’ consensus estimates of ($0.05). Castlight Health, inc. had a negative net margin of 48.72% and a negative return on equity of 43.23%. The company had revenue of $27.70 million during the quarter, compared to analyst estimates of $28.40 million. During the same quarter last year, the business posted ($0.13) EPS. The firm’s revenue for the quarter was up 22.0% on a year-over-year basis. On average, analysts anticipate that Castlight Health, inc. will post ($0.26) EPS for the current fiscal year.

In other Castlight Health, inc. news, CAO Priya Jain sold 7,858 shares of the business’s stock in a transaction that occurred on Wednesday, May 17th. The shares were sold at an average price of $3.65, for a total transaction of $28,681.70. Following the sale, the chief accounting officer now owns 20,000 shares of the company’s stock, valued at approximately $73,000. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Giovanni M. Colella sold 11,456 shares of the business’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $3.75, for a total transaction of $42,960.00. Following the sale, the insider now directly owns 88,094 shares in the company, valued at approximately $330,352.50. The disclosure for this sale can be found here. In the last ninety days, insiders sold 37,051 shares of company stock worth $140,343. Insiders own 37.43% of the company’s stock.

A number of hedge funds have recently added to or reduced their stakes in CSLT. GMT Capital Corp bought a new stake in Castlight Health, inc. during the first quarter valued at $2,568,000. Royce & Associates LP increased its stake in Castlight Health, inc. by 244.7% in the first quarter. Royce & Associates LP now owns 463,709 shares of the software maker’s stock valued at $1,693,000 after buying an additional 329,188 shares in the last quarter. FMR LLC increased its stake in Castlight Health, inc. by 3.4% in the first quarter. FMR LLC now owns 7,665,919 shares of the software maker’s stock valued at $27,980,000 after buying an additional 254,804 shares in the last quarter. Russell Investments Group Ltd. bought a new stake in Castlight Health, inc. during the fourth quarter valued at $1,054,000. Finally, Vanguard Group Inc. increased its stake in Castlight Health, inc. by 7.6% in the first quarter. Vanguard Group Inc. now owns 2,673,760 shares of the software maker’s stock valued at $9,760,000 after buying an additional 189,359 shares in the last quarter. 39.35% of the stock is currently owned by institutional investors.

About Castlight Health, inc.

Castlight Health, Inc offers a health benefits platform that engages employees to make healthcare decisions, and enables employers to communicate and measure their benefit programs. The Company operates through cloud-based products segment. Its technology offering aggregates data and applies analytics to make healthcare data transparent.

Analyst Recommendations for Castlight Health, inc. (NYSE:CSLT)

Receive News & Ratings for Castlight Health inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health inc. and related companies with MarketBeat.com's FREE daily email newsletter.